GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cypress Bioscience, Inc. (CYPB) [hlAlert]

Rating:
Outperform
CYPB
down 3.57 %

Cypress Bioscience, Inc. (CYPB) upgraded to Outperform with price target $9 by Oppenheimer

Posted on: Friday,  Oct 30, 2009  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Cypress Bioscience, Inc. (NASDAQ: CYPB) on 10/30/2009. Previously Oppenheimer rated Perform
Cypress Bioscience, Inc. (NASDAQ: CYPB) on 03/25/2009., when the stock price was $7.34. Since then, Cypress Bioscience, Inc. has lost 8.45% as of 10/30/2009's recent price of $6.72.

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating individualized patient care. The Company focuses to address the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders, such as fibromyalgia and rheumatoid arthritis. In January 2009, the Company received approval from the United States Food and Drug Administration (FDA) to market Savella (milnacipran HCl) for the management of fibromyalgia (FM). On March 4, 2008, Cypress acquired Proprius Pharmaceuticals, Inc. (Proprius), a privately held specialty pharmaceutical company.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/30/2009 8:25 AM Buy
None
6.72 9.00
as of 12/31/2009
1 Week up  8.69 %
1 Month up  22.64 %
3 Months down  -3.27 %
1 YTD up  4.03 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/25/2009 8:25 AM None
None
7.34
12/1/2008 9:25 AM Buy
None
5.23 14.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy